NCT00364039View on ClinicalTrials.gov

Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2006

Conditions
Healthy Subjects
Interventions
DRUG

AV650

Trial Locations (1)

21201

SNBL Clinical Pharmacology Center, Baltimore

Sponsors

Lead Sponsor

Avigen
All Listed Sponsors
lead

Avigen

INDUSTRY

NCT00364039 - Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650 | Biotech Hunter | Biotech Hunter